|
NOTE 16 - Segment and Geographic Information
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting Disclosure [Text Block] |
NOTE 16 —
Segment and Geographic Information
The
Company generates product revenues from wound care products
which are sold into the human and animal healthcare markets,
and the Company generates service revenues from laboratory
testing services which are provided to medical device
manufacturers.
The
Company operates a single segment business for product sales
which consists of three geographical sales territories as
follows (in thousands):
The
Company’s service revenues amounted to $891,000 and
$928,000 for the years ended March 31, 2012 and 2011.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||